Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | AGC family protein kinase | 0.0019 | 0 | 0.5 |
Brugia malayi | cyclin-dependent kinase 9 | 0.0103 | 0.0419 | 0.0579 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0103 | 0.0419 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | G protein-coupled receptor kinase, putative | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Loa Loa (eye worm) | CMGC/CDK/CDK9 protein kinase | 0.0103 | 0.0419 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.0555 | 0.2664 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Schistosoma mansoni | kinase | 0.0103 | 0.0419 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Echinococcus granulosus | cyclin dependent kinase 9 | 0.0121 | 0.0509 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | protein kinase atmrk1, putative | 0.0019 | 0 | 0.5 |
Echinococcus granulosus | cyclin dependent kinase 9 | 0.0103 | 0.0419 | 0.8246 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Echinococcus multilocularis | cyclin dependent kinase 9 | 0.0121 | 0.0509 | 1 |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.0555 | 0.2664 | 1 |
Leishmania major | telomerase reverse transcriptase, putative | 0.0555 | 0.2664 | 1 |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.0555 | 0.2664 | 0.5 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.0555 | 0.2664 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Brugia malayi | Telomerase reverse transcriptase | 0.1477 | 0.7243 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Giardia lamblia | Telomerase catalytic subunit | 0.0555 | 0.2664 | 1 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0555 | 0.2664 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Echinococcus multilocularis | cyclin dependent kinase 9 | 0.0103 | 0.0419 | 0.8246 |
Trichomonas vaginalis | AGC family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | serine/threonine kinase, putative | 0.0019 | 0 | 0.5 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0555 | 0.2664 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0019 | 0 | 0.5 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0103 | 0.0419 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (functional) | 0 uM | The compound was tested for its ability to inhibit AMPA-induced currents in rat brain mRNA-injected xenopus oocytes; Not tested | ChEMBL. | No reference |
Ki (functional) | = 67 uM | Inhibition of kainic acid (KA)-induced currents in rat brain mRNA-injected xenopus oocytes | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.